Skip to main content

Advertisement

Log in

Context-dependent role of Grb7 in HER2+ve and triple-negative breast cancer cell lines

  • Brief Report
  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

Abstract

Grb7 is an adapter protein, aberrantly co-overexpressed with HER2 and identified as an independent prognostic marker in breast cancer. It has been established that Grb7 exacerbates the cellular growth and migratory behaviour of HER2+ve breast cancer cells. Less is known about Grb7’s role in the context of HER2−ve cells. Here we directly compare the effect of stable Grb7 knockdown in oestrogen sensitive (T47D), HER2+ve (SKBR3) and triple-negative (MDA-MB-468 and MDA-MB-231) breast cancer cell lines on anchorage dependent and independent cell growth, wound healing and chemotaxis. All cell lines showed reduced ability to migrate upon Grb7 knockdown, despite their greatly varied endogenous levels of Grb7. Decreased cell proliferation was not observed in any of the cell lines upon Grb7 knockdown; however, decreased ability to form colonies was observed for all but the oestrogen sensitive cell line, depending upon the stringency of the growth conditions. The data reveal that Grb7 plays an important role in breast cancer progression, beyond the context of HER2+ve cell types.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

References

  1. Bell HS, Ryan KM (2005) Intracellular signalling and cancer: complex pathways lead to multiple targets. Eur J Cancer 41(2):206–215. doi:10.1016/j.ejca.2004.10.022

    Article  CAS  PubMed  Google Scholar 

  2. Mitra SK, Hanson DA, Schlaepfer DD (2005) Focal adhesion kinase: in command and control of cell motility. Nat Rev Mol Cell Biol 6(1):56–68. doi:10.1038/nrm1549

    Article  CAS  PubMed  Google Scholar 

  3. Eccles SA (2011) The epidermal growth factor receptor/Erb-B/HER family in normal and malignant breast biology. Int J Dev Biol 55(7–9):685–696. doi:10.1387/ijdb.113396se

    Article  PubMed  Google Scholar 

  4. Stein D, Wu J, Fuqua SA, Roonprapunt C, Yajnik V, D’Eustachio P, Moskow JJ, Buchberg AM, Osborne CK, Margolis B (1994) The SH2 domain protein GRB-7 is co-amplified, overexpressed and in a tight complex with HER2 in breast cancer. EMBO J 13(6):1331–1340

    CAS  PubMed  Google Scholar 

  5. Han DC, Guan JL (1999) Association of focal adhesion kinase with Grb7 and its role in cell migration. J Biol Chem 274(34):24425–24430

    Article  CAS  PubMed  Google Scholar 

  6. Han DC, Shen TL, Guan JL (2000) Role of Grb7 targeting to focal contacts and its phosphorylation by focal adhesion kinase in regulation of cell migration. J Biol Chem 275(37):28911–28917. doi:10.1074/jbc.M00.1997200

    Article  CAS  PubMed  Google Scholar 

  7. Margolis B, Silvennoinen O, Comoglio F, Roonprapunt C, Skolnik E, Ullrich A, Schlessinger J (1992) High-efficiency expression/cloning of epidermal growth factor-receptor-binding proteins with Src homology 2 domains. Proc Natl Acad Sci USA 89(19):8894–8898

    Article  CAS  PubMed  Google Scholar 

  8. Keegan K, Cooper JA (1996) Use of the two hybrid system to detect the association of the protein-tyrosine-phosphatase, SHPTP2, with another SH2-containing protein, Grb7. Oncogene 12(7):1537–1544

    CAS  PubMed  Google Scholar 

  9. Lee H, Volonte D, Galbiati F, Iyengar P, Lublin DM, Bregman DB, Wilson MT, Campos-Gonzalez R, Bouzahzah B, Pestell RG, Scherer PE, Lisanti MP (2000) Constitutive and growth factor-regulated phosphorylation of caveolin-1 occurs at the same site (Tyr-14) in vivo: identification of a c-Src/Cav-1/Grb7 signaling cassette. Mol Endocrinol 14(11):1750–1775

    CAS  PubMed  Google Scholar 

  10. Thommes K, Lennartsson J, Carlberg M, Ronnstrand L (1999) Identification of Tyr-703 and Tyr-936 as the primary association sites for Grb2 and Grb7 in the c-Kit/stem cell factor receptor. Biochem J 341(Pt 1):211–216

    Article  CAS  PubMed  Google Scholar 

  11. Han DC, Shen TL, Miao H, Wang B, Guan JL (2002) EphB1 associates with Grb7 and regulates cell migration. J Biol Chem 277(47):45655–45661. doi:10.1074/jbc.M203165200

    Article  CAS  PubMed  Google Scholar 

  12. Jones N, Master Z, Jones J, Bouchard D, Gunji Y, Sasaki H, Daly R, Alitalo K, Dumont DJ (1999) Identification of Tek/Tie2 binding partners. Binding to a multifunctional docking site mediates cell survival and migration. J Biol Chem 274(43):30896–30905

    Article  CAS  PubMed  Google Scholar 

  13. Tanaka S, Mori M, Akiyoshi T, Tanaka Y, Mafune K, Wands JR, Sugimachi K (1997) Coexpression of Grb7 with epidermal growth factor receptor or Her2/erbB2 in human advanced esophageal carcinoma. Cancer Res 57(1):28–31

    CAS  PubMed  Google Scholar 

  14. Kishi T, Sasaki H, Akiyama N, Ishizuka T, Sakamoto H, Aizawa S, Sugimura T, Terada M (1997) Molecular cloning of human GRB-7 co-amplified with CAB1 and c-ERBB-2 in primary gastric cancer. Biochem Biophys Res Commun 232(1):5–9. doi:10.1006/bbrc.1997.6218

    Article  CAS  PubMed  Google Scholar 

  15. Tanaka S, Pero SC, Taguchi K, Shimada M, Mori M, Krag DN, Arii S (2006) Specific peptide ligand for Grb7 signal transduction protein and pancreatic cancer metastasis. J Natl Cancer Inst 98(7):491–498. doi:10.1093/jnci/djj105

    Article  CAS  PubMed  Google Scholar 

  16. Wang Y, Chan DW, Liu VW, Chiu P, Ngan HY (2010) Differential functions of growth factor receptor-bound protein 7 (GRB7) and its variant GRB7v in ovarian carcinogenesis. Clin Cancer Res 16(9):2529–2539. doi:10.1158/1078-0432.CCR-10-0018

    Article  CAS  PubMed  Google Scholar 

  17. Bai T, Luoh SW (2008) GRB-7 facilitates HER-2/Neu-mediated signal transduction and tumor formation. Carcinogenesis 29(3):473–479. doi:10.1093/carcin/bgm221

    Article  CAS  PubMed  Google Scholar 

  18. Birnbaum D, Sircoulomb F, Imbert J (2009) A reason why the ERBB2 gene is amplified and not mutated in breast cancer. Cancer Cell Int 9:5. doi:10.1186/1475-2867-9-5

    Article  PubMed Central  PubMed  Google Scholar 

  19. Kao J, Pollack JR (2006) RNA interference-based functional dissection of the 17q12 amplicon in breast cancer reveals contribution of coamplified genes. Genes Chromosomes Cancer 45(8):761–769. doi:10.1002/gcc.20339

    Article  CAS  PubMed  Google Scholar 

  20. Nadler Y, Gonzalez AM, Camp RL, Rimm DL, Kluger HM, Kluger Y (2010) Growth factor receptor-bound protein-7 (Grb7) as a prognostic marker and therapeutic target in breast cancer. Ann Oncol 21(3):466–473. doi:10.1093/annonc/mdp346

    Article  CAS  PubMed  Google Scholar 

  21. Ramsey B, Bai T, Hanlon Newell A, Troxell M, Park B, Olson S, Keenan E, Luoh SW (2010) GRB7 protein over-expression and clinical outcome in breast cancer. Breast Cancer Res Treat 127(3):659–669. doi:10.1007/s10549-010-1010-0

    Article  PubMed  Google Scholar 

  22. Nencioni A, Cea M, Garuti A, Passalacqua M, Raffaghello L, Soncini D, Moran E, Zoppoli G, Pistoia V, Patrone F, Ballestrero A (2010) Grb7 upregulation is a molecular adaptation to HER2 signaling inhibition due to removal of Akt-mediated gene repression. PLoS One 5(2):e9024. doi:10.1371/journal.pone.0009024

    Article  PubMed Central  PubMed  Google Scholar 

  23. Ooi J, Yajnik V, Immanuel D, Gordon M, Moskow JJ, Buchberg AM, Margolis B (1995) The cloning of Grb10 reveals a new family of SH2 domain proteins. Oncogene 10(8):1621–1630

    CAS  PubMed  Google Scholar 

  24. Daly RJ, Sanderson GM, Janes PW, Sutherland RL (1996) Cloning and characterization of GRB14, a novel member of the GRB7 gene family. J Biol Chem 271(21):12502–12510

    Article  CAS  PubMed  Google Scholar 

  25. Han DC, Shen TL, Guan JL (2001) The Grb7 family proteins: structure, interactions with other signaling molecules and potential cellular functions. Oncogene 20(44):6315–6321. doi:10.1038/sj.onc.1204775

    Article  CAS  PubMed  Google Scholar 

  26. Chu PY, Li TK, Ding ST, Lai IR, Shen TL (2010) EGF-induced Grb7 recruits and promotes Ras activity essential for the tumorigenicity of Sk-Br3 breast cancer cells. J Biol Chem 285(38):29279–29285. doi:10.1074/jbc.C110.114124

    Article  CAS  PubMed  Google Scholar 

  27. Chu PY, Huang LY, Hsu CH, Liang CC, Guan JL, Hung TH, Shen TL (2009) Tyrosine phosphorylation of growth factor receptor-bound protein-7 by focal adhesion kinase in the regulation of cell migration, proliferation, and tumorigenesis. J Biol Chem 284(30):20215–20226. doi:10.1074/jbc.M109.018259

    Article  CAS  PubMed  Google Scholar 

  28. Pradip D, Bouzyk M, Dey N, Leyland-Jones B (2013) Dissecting GRB7-mediated signals for proliferation and migration in HER2 overexpressing breast tumor cells: GTP-ase rules. Am J Cancer Res 3(2):173–195

    PubMed Central  PubMed  Google Scholar 

  29. Giricz O, Calvo V, Pero SC, Krag DN, Sparano JA, Kenny PA (2011) GRB7 is required for triple-negative breast cancer cell invasion and survival. Breast Cancer Res Treat. doi:10.1007/s10549-011-1822-6

    PubMed  Google Scholar 

  30. Pero SC, Shukla GS, Cookson MM, Flemer S Jr, Krag DN (2007) Combination treatment with Grb7 peptide and Doxorubicin or Trastuzumab (Herceptin) results in cooperative cell growth inhibition in breast cancer cells. Br J Cancer 96(10):1520–1525. doi:10.1038/sj.bjc.6603732

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  31. Perou CM, Sorlie T, Eisen MB, van de Rijn M, Jeffrey SS, Rees CA, Pollack JR, Ross DT, Johnsen H, Akslen LA, Fluge O, Pergamenschikov A, Williams C, Zhu SX, Lonning PE, Borresen-Dale AL, Brown PO, Botstein D (2000) Molecular portraits of human breast tumours. Nature 406(6797):747–752. doi:10.1038/35021093

    Article  CAS  PubMed  Google Scholar 

  32. Cianfrocca M, Gradishar W (2009) New molecular classifications of breast cancer. CA Cancer J Clin 59(5):303–313. doi:10.3322/caac.20029

    Article  PubMed  Google Scholar 

  33. Guo L, Fan D, Zhang F, Price JE, Lee J-S, Marchetti D, Fidler IJ, Langley RR (2011) Selection of brain metastasis-initiating breast cancer cells determined by growth on hard agar. Am J Pathol 178(5):2357–2366

    Article  CAS  PubMed  Google Scholar 

  34. Tanaka S, Mori M, Akiyoshi T, Tanaka Y, Mafune K, Wands JR, Sugimachi K (1998) A novel variant of human Grb7 is associated with invasive esophageal carcinoma. J Clin Invest 102(4):821–827. doi:10.1172/JCI2921

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  35. Tanaka S, Sugimachi K, Kawaguchi H, Saeki H, Ohno S, Wands JR (2000) Grb7 signal transduction protein mediates metastatic progression of esophageal carcinoma. J Cell Physiol 183(3):411–415. doi:10.1002/(SICI)1097-4652(200006)183:3<411:AID-JCP14>3.0.CO;2-Z

    Google Scholar 

  36. Sparano JA, Goldstein LJ, Childs BH, Shak S, Brassard D, Badve S, Baehner FL, Bugarini R, Rowley S, Perez EA, Shulman LN, Martino S, Davidson NE, Kenny PA, Sledge GW Jr, Gray R (2011) Relationship between quantitative GRB7 RNA expression and recurrence after adjuvant anthracycline chemotherapy in triple-negative breast cancer. Clin Cancer Res 17(22):1–10. doi:10.1158/1078-0432.CCR-10-3357

    Article  Google Scholar 

Download references

Acknowledgments

We thank Monash Micro Imaging for assistance with live cell microscopy and imaging, and Monash Flowcore for assistance with FACS.

Conflict of interest

The authors declare they have no conflicts of interest.

Funding

This work was supported by the National Health and Medical Research Council of Australia [APP1004332 awarded to JAW and JP] and National Health and Medical Research Council of Australia RD Wright Fellowship [#395525 awarded to JP].

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jacqueline A. Wilce.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lim, R.C.C., Price, J.T. & Wilce, J.A. Context-dependent role of Grb7 in HER2+ve and triple-negative breast cancer cell lines. Breast Cancer Res Treat 143, 593–603 (2014). https://doi.org/10.1007/s10549-014-2838-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10549-014-2838-5

Keywords

Navigation